Back to Rounds
Series A Round
Funding Details
CrossBridgeBio is developing a dual payload platform for non-GLP NHP toxicity data, aiming to revolutionize the way toxicity assessments are conducted in preclinical studies. Their innovative approach seeks to improve the accuracy and efficiency of toxicity testing, ultimately accelerating the drug development process.
Valuation
- Pre-money: $60000000.0M
- Post-money: $75000000.0M
Confidence Score
Participating Investors
No investors recorded for this funding round.
Related Tweets
No tweets found for this funding round.